|
MechanismNMDA receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date29 Oct 2010 |
100 Clinical Results associated with Jenson Pharmaceutical Services Limited
0 Patents (Medical) associated with Jenson Pharmaceutical Services Limited
100 Deals associated with Jenson Pharmaceutical Services Limited
100 Translational Medicine associated with Jenson Pharmaceutical Services Limited